Lancet:常规插管后的张力性水气心包

2015-05-04 MedSci MedSci原创

2014年6月,一个患有晚期肾病和慢性尿毒症心包积液的37岁病人来到我们机构,伴随逐渐恶化的呼吸困难和端坐呼吸,肾切除手术4天后控制高血压。他在拒绝移植肾的前9年每周3次定期进行血液透析。检查静息时病人出现严重呼吸困难,脉搏102次每分钟,呼吸率20次每分钟,血压110/70 mm Hg,伴有25mm Hg诡异变化。肺听诊显示基部支气管呼吸声。胸部X线表明有气-液水平的心脏肥大。胸部CT显示心包积

2014年6月,一个患有晚期肾病和慢性尿毒症心包积液的37岁病人来到我们机构,伴随逐渐恶化的呼吸困难和端坐呼吸,肾切除手术4天后控制高血压。他在拒绝移植肾的前9年每周3次定期进行血液透析。检查静息时病人出现严重呼吸困难,脉搏102次每分钟,呼吸率20次每分钟,血压110/70 mm Hg,伴有25mm Hg诡异变化。肺听诊显示基部支气管呼吸声。胸部X线表明有气-液水平的心脏肥大。胸部CT显示心包积水充气。超声波心动描记术显示巨大心包渗漏引起二尖瓣流入超过25%的呼吸变异,与心包填塞生理学一致。我们做了一个心包窗口,并流出大概1L的血清血液流体。心包液培养为阴性,心包活组织检查分析显示急性和慢性炎症和纤维化。治疗性引流后病人住院治疗情况平静。2周后,后续超声波心动描记术显示只有轻微心包积液。在2014年12月,病人好了,超声波心动描记术显示只有轻微心包积液。2015年3月,病人状态良好,但在纳马齐教学医学继续保持血液透析。


 
Figure Hydropneumopericardium

Posteroanterior (A) and lateral (B) chest radiographs showing cardiomegaly with an air–fluid level at the heart level. (C) Transverse CT showing hydropneumopericardium.

心包积气通常发生在钝挫伤或穿透性胸外伤后,但是偶尔也会发生于插管和机械通风。除了最近肾切除术插管外,我们没有发现病人其它风险因素。心包积气极少叠加于已存在心包积液而导致紧张性水气心包,像我们的病人这样。普通放射成像类似于大量食管裂孔疝或胃扭转;包含气液水平的心脏边界描绘有助于排除这些鉴别诊断。

原始出处:

Prof Mohammad Ali Ghayumi, MD, Dr Mohammad Javad Fallahi, MD, Seyed Masoom Masoompour, MD, Prof Jamshid Roozbeh, MD.Tension hydropneumopericardium after routine intubation. Lancet, April 30, 2015. DOI: http://dx.doi.org/10.1016/S0140-6736(15)60028-9

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=35710, encodeId=39da35e1080, content=特殊病例学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f0d1608613, createdName=jxsrdw, createdTime=Mon Aug 17 11:06:00 CST 2015, time=2015-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828089, encodeId=374e182808900, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 10 23:27:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774730, encodeId=a2f91e747306d, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Jun 30 00:27:00 CST 2015, time=2015-06-30, status=1, ipAttribution=)]
    2015-08-17 jxsrdw

    特殊病例学习了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=35710, encodeId=39da35e1080, content=特殊病例学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f0d1608613, createdName=jxsrdw, createdTime=Mon Aug 17 11:06:00 CST 2015, time=2015-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828089, encodeId=374e182808900, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 10 23:27:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774730, encodeId=a2f91e747306d, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Jun 30 00:27:00 CST 2015, time=2015-06-30, status=1, ipAttribution=)]
    2015-05-10 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=35710, encodeId=39da35e1080, content=特殊病例学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f0d1608613, createdName=jxsrdw, createdTime=Mon Aug 17 11:06:00 CST 2015, time=2015-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828089, encodeId=374e182808900, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 10 23:27:00 CST 2015, time=2015-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774730, encodeId=a2f91e747306d, content=<a href='/topic/show?id=aa9c499213d' target=_blank style='color:#2F92EE;'>#张力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49921, encryptionId=aa9c499213d, topicName=张力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff6f38676471, createdName=zhmscau, createdTime=Tue Jun 30 00:27:00 CST 2015, time=2015-06-30, status=1, ipAttribution=)]
    2015-06-30 zhmscau

相关资讯

Chest:肺动脉高压患者出现心包积液预示其死亡风险显著增加

肺动脉高压(PAH)患者心包积液的发生状况及其对患者预后的影响目前仍不清楚。为了加深对这一问题的认识,来自美国明尼苏达州罗切斯特市梅奥诊所心内科的Garvan C. Kane博士及其同事进行了一项研究,研究结果在线发表于2013年8月15日的《CHEST》杂志上。 【原文阅读】 研究结果显示:心包积液在PAH患者中较常见,尽管其很少具有血流动力学意义,但即使是轻度的心包积液也与患者死亡率的显著增